Caruso, Michele <br/><br/>
3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.  [electronic resource] 

 -  Future oncology (London, England)  2015 
 - 3109-12 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon.15.261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Female<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Neoplasm Staging<br/>Premenopause<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone<br/>Treatment Outcome<br/>Triptorelin Pamoate--therapeutic use